-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Lowered to $119 at Morgan Stanley
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $100 at Stephens
-
-
-
-
-
-
-
Kymera begins dosing first patient in phase 2b asthma trial
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $122 at Jefferies
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $114 at Stifel
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $67 at Oppenheimer
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $63 at Oppenheimer
-
418,385 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

